Skip to main contentClarixos
The problemClinical → clearThe productEvaluationContact
01The problem02Clinical → clear03The product04Evaluation05Contact06Accessibility07Privacy

Using this website

Accessibility at Clarixos.

We want this experimental website to be usable by as many people as possible.

Prepared and last reviewed · 7 October 2026

Our current target

WCAG 2.2 AA is the design and self-assessment target for this website. The site has not received a third-party assessment, and this statement does not claim complete conformance.

Our current self-assessment includes automated semantic checks and manual browser checks of keyboard access, focus, contrast and narrow-screen reflow. Physical-phone and dedicated screen-reader testing remain outstanding, so these checks do not establish complete conformance. We will update this page as further testing identifies issues.

What the website supports

  • Keyboard access to navigation, term selection and reader controls.
  • A skip-to-content link and a keyboard bypass for the cinematic opening.
  • Visible focus indicators and descriptive control labels.
  • Semantic headings, landmarks, buttons, tabs and live updates.
  • Reflow for narrow screens and enlarged text.
  • High-contrast text and non-colour state indicators.
  • A reduced-motion presentation when requested by the device.
  • Primary controls designed to remain at least 44 pixels high.
  • A labelled contact form with text errors, focus on the first invalid field and announced submission results.

Feedback and alternative formats

If any part of this website is difficult to use, or if you need its information in another format, email yusufsoliman@clarixos.health. Please describe the page and the problem you encountered, without sending patient records or identifiable clinical information.

If JavaScript is unavailable, the contact page provides a direct email alternative.

Scope of this statement

This statement covers the current Clarixos marketing website. It does not describe a future clinical product or service.

If you work with patient correspondence, we would like to hear from you.

We are speaking with clinicians, communication leads and patient groups as we develop and evaluate our approach.

Start a conversationyusufsoliman@clarixos.health
AccessibilityPrivacy
Clarixos

CLARIXOS LTD

Company number 16894744

Registered office: 15 Cobbins Brook Way, Dunmow, England, CM6 4DF

Registered in England and Wales

Developing and evaluating. Not a medical device. Not a substitute for advice from your clinical team. All correspondence shown is illustrative and synthetic.